Lei Li is the managing partner of Sidley Austin's Beijing and Shanghai offices, and a member of the firm's life sciences practice team in China.
From 2007, Mr Li has focused his practice on advising pharmaceutical and medical device companies, both multinational and local, on complex regulatory matters in China, such as product registration, clinical trials, drug and device pricing and reimbursement, drug promotion and advertisement, GSP and GMP compliance, etc. He also advises these companies on commercial and corporate transactions in China, such as drug and device distribution, licensing, co-promotion and co-marketing, and M&A and spin-offs.
Before returning to the firm's China office, Mr Li practised at the firm's New York office for three years on pharmaceutical regulatory law (primarily clinical trials and product registrations). Prior to joining the firm, Mr Li worked at the Ministry of Commerce (MOFCOM) of China for eight years as a government attorney.